The visit to the Bio Science Park at Leiden University was coordinated by drs. Jaap Blaak, and it provided a look into the ever growing field of biotechnology. We had 4 presentations, 2 of which were from the CEOs of start up biotechnology companies (to-BBB and FlexGen). To-BBB is involved in modifying the delivery system of drugs for better entry into the brain. This technology may prove to be invaluable in the treatment of diseases of the brain with efficacious drugs that would otherwise have poor penetration. FlexGen has created a prototype instrument that can produce custom DNA microarrays within 24 hours. DNA microarrays play an important role in genetic research and medical diagnosis and potentially in population disease surveillance.
The Netherlands, small in land mass, big in innovation.
No comments:
Post a Comment